26
Participants
Start Date
January 31, 2004
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
MB-002
Dendritic Cell Immunotherapy
Roswell Park Cancer Institute, Buffalo
University of North Carolina at Chapel Hill, Chapel Hill
University of California - Irvine, Orange
Princess Margaret Hospital, Toronto
Jewish General Hospital, Montreal
Lead Sponsor
Argos Therapeutics
INDUSTRY